Unmasking the deceptive nature of cancer stem cells: The role of cd133 in revealing their secrets

J Pospieszna, H Dams-Kozlowska, W Udomsak… - International Journal of …, 2023 - mdpi.com
Cancer remains a leading cause of death globally, and its complexity poses a significant
challenge to effective treatment. Cancer stem cells and their markers have become key …

Regulation of cancer stem cells and immunotherapy of glioblastoma

А Kosianova, O Pak… - Biomedical …, 2023 - spandidos-publications.com
Glioblastoma (GB) is one of the most adverse diagnoses in oncology. Complex current
treatment results in a median survival of 15 months. Resistance to treatment is associated …

Clinical significance of cancer stem cell markers in primary and metastatic tissues in patients with breast cancer

T Yamanaka, T Oshima, D Murayama… - Anticancer …, 2023 - ar.iiarjournals.org
Background/Aim: This study aimed to examine the clinical significance of the protein
expression of the cancer stem cell (CSC) markers ALDH1A1, CD133, CD44, and MSI-1 in …

CD133 ligand‐enhanced etoposide‐liposome complex for targeted killing of lung cancer cells

S Nie, J Zhou, X Zheng, X Wei, J Zhang… - Biotechnology …, 2024 - Wiley Online Library
Lung cancer has a high incidence rate and a low cure rate, hence the urgent need for
effective treatment methods. Current lung cancer drugs have several drawbacks, including …

Hippo Signaling Pathway in Cancer Stem Cell

W Shen, Z Weijian, XU Hongting, X Xiangqian - Authorea Preprints, 2023 - techrxiv.org
In recent years, how to inhibit the proliferation of tumor cells and the expression of stem
genes has become one of the focuses of scientists in treating cancer. Cancer stem cell …

[PDF][PDF] Detektion und Charakterisierung von Tumorstammzellen in Mammakarzinom-Zelllinien

J Tübing - zhb.uni-luebeck.de
Das Mammakarzinom ist die häufigste krebsbedingte Todesursache bei Frauen. Klinische
Therapiestrategien operieren unter der Annahme, dass alle Tumorzellen das gleiche …